WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics, today announced that the Company will report its financial results for the third quarter ended September 30, 2010 on Thursday, November 4, 2010, after the financial markets close. Following the release of the financial results, Allos management will provide a corporate update and review of the third quarter 2010 results via audio webcast conference call on Thursday, November 4, 2010, at 4:30 p.m. Eastern Time (ET).
